List of Tables
Table 1. Global Non-opioid Pain Med Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Non-opioid Pain Med Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Non-opioid Pain Med Market Competitive Situation by Manufacturers in 2024
Table 4. Global Non-opioid Pain Med Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Non-opioid Pain Med Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Non-opioid Pain Med Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Non-opioid Pain Med Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Non-opioid Pain Med Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Non-opioid Pain Med, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-opioid Pain Med, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-opioid Pain Med, Product Type & Application
Table 12. Global Key Manufacturers of Non-opioid Pain Med, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-opioid Pain Med by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Med as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-opioid Pain Med Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Non-opioid Pain Med Sales by Region (2020-2025) & (K Units)
Table 18. Global Non-opioid Pain Med Sales Market Share by Region (2020-2025)
Table 19. Global Non-opioid Pain Med Sales by Region (2026-2031) & (K Units)
Table 20. Global Non-opioid Pain Med Sales Market Share by Region (2026-2031)
Table 21. Global Non-opioid Pain Med Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Non-opioid Pain Med Revenue Market Share by Region (2020-2025)
Table 23. Global Non-opioid Pain Med Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Non-opioid Pain Med Revenue Market Share by Region (2026-2031)
Table 25. North America Non-opioid Pain Med Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Non-opioid Pain Med Sales by Country (2020-2025) & (K Units)
Table 27. North America Non-opioid Pain Med Sales by Country (2026-2031) & (K Units)
Table 28. North America Non-opioid Pain Med Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Non-opioid Pain Med Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Non-opioid Pain Med Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Non-opioid Pain Med Sales by Country (2020-2025) & (K Units)
Table 32. Europe Non-opioid Pain Med Sales by Country (2026-2031) & (K Units)
Table 33. Europe Non-opioid Pain Med Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Non-opioid Pain Med Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Non-opioid Pain Med Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Non-opioid Pain Med Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Non-opioid Pain Med Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Non-opioid Pain Med Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Non-opioid Pain Med Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-opioid Pain Med Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Non-opioid Pain Med Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Non-opioid Pain Med Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Non-opioid Pain Med Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Non-opioid Pain Med Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Non-opioid Pain Med Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Non-opioid Pain Med Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Non-opioid Pain Med Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Non-opioid Pain Med Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Non-opioid Pain Med Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Non-opioid Pain Med Sales (K Units) by Type (2020-2025)
Table 51. Global Non-opioid Pain Med Sales (K Units) by Type (2026-2031)
Table 52. Global Non-opioid Pain Med Sales Market Share by Type (2020-2025)
Table 53. Global Non-opioid Pain Med Sales Market Share by Type (2026-2031)
Table 54. Global Non-opioid Pain Med Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Non-opioid Pain Med Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Non-opioid Pain Med Revenue Market Share by Type (2020-2025)
Table 57. Global Non-opioid Pain Med Revenue Market Share by Type (2026-2031)
Table 58. Global Non-opioid Pain Med Price (US$/Unit) by Type (2020-2025)
Table 59. Global Non-opioid Pain Med Price (US$/Unit) by Type (2026-2031)
Table 60. Global Non-opioid Pain Med Sales (K Units) by Application (2020-2025)
Table 61. Global Non-opioid Pain Med Sales (K Units) by Application (2026-2031)
Table 62. Global Non-opioid Pain Med Sales Market Share by Application (2020-2025)
Table 63. Global Non-opioid Pain Med Sales Market Share by Application (2026-2031)
Table 64. Global Non-opioid Pain Med Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Non-opioid Pain Med Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Non-opioid Pain Med Revenue Market Share by Application (2020-2025)
Table 67. Global Non-opioid Pain Med Revenue Market Share by Application (2026-2031)
Table 68. Global Non-opioid Pain Med Price (US$/Unit) by Application (2020-2025)
Table 69. Global Non-opioid Pain Med Price (US$/Unit) by Application (2026-2031)
Table 70. WEX Pharmaceuticals Inc. Company Information
Table 71. WEX Pharmaceuticals Inc. Description and Business Overview
Table 72. WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. WEX Pharmaceuticals Inc. Non-opioid Pain Med Product
Table 74. WEX Pharmaceuticals Inc. Recent Developments/Updates
Table 75. BASF Company Information
Table 76. BASF Description and Business Overview
Table 77. BASF Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BASF Non-opioid Pain Med Product
Table 79. BASF Recent Developments/Updates
Table 80. Xinhua Pharm Company Information
Table 81. Xinhua Pharm Description and Business Overview
Table 82. Xinhua Pharm Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Xinhua Pharm Non-opioid Pain Med Product
Table 84. Xinhua Pharm Recent Developments/Updates
Table 85. Johnson & Johnson（McNeil Consumer Healthcare） Company Information
Table 86. Johnson & Johnson（McNeil Consumer Healthcare） Description and Business Overview
Table 87. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Product
Table 89. Johnson & Johnson（McNeil Consumer Healthcare） Recent Developments/Updates
Table 90. Granules Biocause Company Information
Table 91. Granules Biocause Description and Business Overview
Table 92. Granules Biocause Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Granules Biocause Non-opioid Pain Med Product
Table 94. Granules Biocause Recent Developments/Updates
Table 95. Novacyl Company Information
Table 96. Novacyl Description and Business Overview
Table 97. Novacyl Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Novacyl Non-opioid Pain Med Product
Table 99. Novacyl Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Pfizer Non-opioid Pain Med Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Hisoar Company Information
Table 106. Hisoar Description and Business Overview
Table 107. Hisoar Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Hisoar Non-opioid Pain Med Product
Table 109. Hisoar Recent Developments/Updates
Table 110. Anant Pharmaceuticals Pvt. Ltd. Company Information
Table 111. Anant Pharmaceuticals Pvt. Ltd. Description and Business Overview
Table 112. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product
Table 114. Anant Pharmaceuticals Pvt. Ltd. Recent Developments/Updates
Table 115. Strides Shasun Company Information
Table 116. Strides Shasun Description and Business Overview
Table 117. Strides Shasun Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Strides Shasun Non-opioid Pain Med Product
Table 119. Strides Shasun Recent Developments/Updates
Table 120. SI Group Company Information
Table 121. SI Group Description and Business Overview
Table 122. SI Group Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. SI Group Non-opioid Pain Med Product
Table 124. SI Group Recent Developments/Updates
Table 125. Elam Pharma Company Information
Table 126. Elam Pharma Description and Business Overview
Table 127. Elam Pharma Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Elam Pharma Non-opioid Pain Med Product
Table 129. Elam Pharma Recent Developments/Updates
Table 130. AdvaCare Pharma Company Information
Table 131. AdvaCare Pharma Description and Business Overview
Table 132. AdvaCare Pharma Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. AdvaCare Pharma Non-opioid Pain Med Product
Table 134. AdvaCare Pharma Recent Developments/Updates
Table 135. IOL Company Information
Table 136. IOL Description and Business Overview
Table 137. IOL Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. IOL Non-opioid Pain Med Product
Table 139. IOL Recent Developments/Updates
Table 140. Jingye Group Company Information
Table 141. Jingye Group Description and Business Overview
Table 142. Jingye Group Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Jingye Group Non-opioid Pain Med Product
Table 144. Jingye Group Recent Developments/Updates
Table 145. NS Chemicals Company Information
Table 146. NS Chemicals Description and Business Overview
Table 147. NS Chemicals Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. NS Chemicals Non-opioid Pain Med Product
Table 149. NS Chemicals Recent Developments/Updates
Table 150. Hunan Zhongnan Pharmaceutical Company Information
Table 151. Hunan Zhongnan Pharmaceutical Description and Business Overview
Table 152. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product
Table 154. Hunan Zhongnan Pharmaceutical Recent Developments/Updates
Table 155. Nanjing Pharmaceutical Factory Company Information
Table 156. Nanjing Pharmaceutical Factory Description and Business Overview
Table 157. Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Nanjing Pharmaceutical Factory Non-opioid Pain Med Product
Table 159. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 160. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Company Information
Table 161. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 162. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product
Table 164. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 165. Mallinckrodt Pharmaceuticals Company Information
Table 166. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 167. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product
Table 169. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Non-opioid Pain Med Distributors List
Table 173. Non-opioid Pain Med Customers List
Table 174. Non-opioid Pain Med Market Trends
Table 175. Non-opioid Pain Med Market Drivers
Table 176. Non-opioid Pain Med Market Challenges
Table 177. Non-opioid Pain Med Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-opioid Pain Med
Figure 2. Global Non-opioid Pain Med Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-opioid Pain Med Market Share by Type: 2024 & 2031
Figure 4. Diclofenac Sodium Product Picture
Figure 5. Acetaminophen Product Picture
Figure 6. Indomethacin Product Picture
Figure 7. Ibuprofen Product Picture
Figure 8. Aspirin Product Picture
Figure 9. Others Product Picture
Figure 10. Global Non-opioid Pain Med Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Non-opioid Pain Med Market Share by Application: 2024 & 2031
Figure 12. Mild Pain
Figure 13. Moderate Pain
Figure 14. Global Non-opioid Pain Med Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Non-opioid Pain Med Market Size (2020-2031) & (US$ Million)
Figure 16. Global Non-opioid Pain Med Sales (2020-2031) & (K Units)
Figure 17. Global Non-opioid Pain Med Average Price (US$/Unit) & (2020-2031)
Figure 18. Non-opioid Pain Med Report Years Considered
Figure 19. Non-opioid Pain Med Sales Share by Manufacturers in 2024
Figure 20. Global Non-opioid Pain Med Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Non-opioid Pain Med Players: Market Share by Revenue in Non-opioid Pain Med in 2024
Figure 22. Non-opioid Pain Med Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Non-opioid Pain Med Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Non-opioid Pain Med Sales Market Share by Country (2020-2031)
Figure 25. North America Non-opioid Pain Med Revenue Market Share by Country (2020-2031)
Figure 26. United States Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Non-opioid Pain Med Sales Market Share by Country (2020-2031)
Figure 29. Europe Non-opioid Pain Med Revenue Market Share by Country (2020-2031)
Figure 30. Germany Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Non-opioid Pain Med Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Non-opioid Pain Med Revenue Market Share by Region (2020-2031)
Figure 37. China Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Non-opioid Pain Med Sales Market Share by Country (2020-2031)
Figure 45. Latin America Non-opioid Pain Med Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Non-opioid Pain Med Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Non-opioid Pain Med Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Non-opioid Pain Med Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Non-opioid Pain Med by Type (2020-2031)
Figure 55. Global Revenue Market Share of Non-opioid Pain Med by Type (2020-2031)
Figure 56. Global Non-opioid Pain Med Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Non-opioid Pain Med by Application (2020-2031)
Figure 58. Global Revenue Market Share of Non-opioid Pain Med by Application (2020-2031)
Figure 59. Global Non-opioid Pain Med Price (US$/Unit) by Application (2020-2031)
Figure 60. Non-opioid Pain Med Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
